Physician profile
Nikki Rowan
NPI 1841354669
$1,038.44
in general payments reported to CMS, 2019-2025
16 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.07 · 2022: $36.01 · 2023: $423 · 2024: $281 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.09 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $194.81 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $153.84 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $142.08 | 2023-2025 | Wegovy |
| Pfizer INC. | $126.95 | 2022-2024 | |
| Organon LLC | $70.51 | 2022-2025 | Nexplanon |
| Viiv Healthcare Company | $64.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.62 | 2023 | |
| Applied Medical Resources Corporation | $39.44 | 2023 | |
| Mayne Pharma Commercial LLC | $35.75 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $31.13 | 2024-2025 | Myfembree |
| Exeltis, USA INC. | $30.32 | 2021-2023 | Slynd |
| Evofem Biosciences, INC. | $22.68 | 2023 | Phexxi |
| Abbvie INC. | $22.33 | 2023 | Lo Loestrin Fe, Orilissa |
| Davol INC. | $19.29 | 2024 | Arista Ah Flexitip |
| Astellas Pharma US INC | $17.22 | 2023 | Myrbetriq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $17.00 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikki Rowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.